Gadolinium-based Contrast Agents: Class Labeling Change – Risk of Nephrogenic Systemic Fibrosis

Audience: Radiology, Nephrology, Dermatology Ablavar (gadofosveset trisodium), Eovist (gadoxetate disodium), Magnevist (gadopentetate dimeglumine), Multihance (gadobenate dimeglumine), Omniscan (gadodiamide), Optimark (gadoversetamide injection),…



No related posts.